[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369173-105":59,"doc-detail-369173-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","site-specific-immunoglobulin-g-n-glycosylation-is-associated-with-gastric-cancer-progression","Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression","","Cancer progression is tightly linked to alterations in IgG N-glycosylation, yet gastric cancer still lacks comprehensive N-glycome and N-glycoproteome profiling. The prognostic value of IgG N-glycan patterns for identifying precursors has not been fully clarified. This study applies high-throughput orthogonal mass spectrometry to define IgG glycomic changes in gastric cancer, integrate multivariate statistics, and evaluate related gene expression, including IL-11 quantification by ELISA.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/site-specific-immunoglobulin-g-n-glycosylation-is-associated-with-gastric-cancer-progression/369173/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/site-specific-immunoglobulin-g-n-glycosylation-is-associated-with-gastric-cancer-progression/369173.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is profiling IgG N-glycosylation important in gastric cancer?","Question",{"text":113,"@type":114},"IgG N-glycosylation alterations are well linked to cancer development, but comprehensive profiling in gastric cancer has been limited. The study aims to clarify prognostic and precursor identification potential of IgG N-glycan patterns.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the IgG N-glycome characterized?",{"text":118,"@type":114},"The IgG N-glycome in gastric cancer was characterized using a custom high-throughput orthogonal mass spectrometry approach. Multivariate analysis and bioinformatics were used to identify glycomic alterations and related gene expression changes.",{"name":120,"@type":111,"acceptedAnswer":121},"What biomarkers did the study highlight for gastric cancer progression?",{"text":122,"@type":114},"Subclass-specific changes in IgG N-glycosylation, including decreased galactosylation and sialylation in IgG1 and IgG2, were associated with gastric cancer. Specific IgG glycopeptides showed strong diagnostic performance and the abundance correlated with serum IL-11 levels.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369173,1790211964,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Xu etal. BMC Cancer (2025) 25:217 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-13616-z](https://doi.org/10.1186/s12885-025-13616-z)  \nRESEARCH Open Access  \nSite-specific immunoglobulin G  \nN-glycosylation is associated with gastric cancer progression  \nTingting Xu 1†, Jianmin Huang2†, Jiajing Lin3, Yuanyuan Liu3, Yi Wang4, Wenkang Shen3, Jianjie He3, Shuyun Chen 1, Xi Zhu 1, Yuqin Que 1, Mengting Hu 1, Yu Chen 1, Liming Cheng4, Honghao He5, Xin Liu3* and Si Liu 1*  \nAbstract  \nBackground The relationship between cancer development and alterations in IgG N-glycosylation has been well-established. However, comprehensive profiling of the N-glycome and N-glycoproteome in gastric cancer (GC) remains limited. Furthermore, the prognostic potential of IgG N-glycan patterns in identifying precursors to GC has yet to be fully elucidated.  \nMethods The IgG N-glycome in GC was characterized using a custom high-throughput orthogonal mass spectrometry approach. Multivariate analysis was employed to identify and assess glycomic alterations. A comprehensive bioinformatics analysis was also conducted to investigate the differential expression of  \nN-glycosylation-related genes and their potential roles in GC pathogenesis. Additionally, interleukin-11 (IL-11) levels were quantified using a standardized enzyme-linked immunosorbent assay (ELISA) .  \nResults Galactosylation and sialylation of IgG decreased mainly in the IgG1 and IgG2 subclasses in GC, with subclass-specific changes in IgG3 and IgG4 galactosylation. These glycan modifications were represented by unique glycopeptides (IgG1_H5N5, IgG2_H4N3F1, IgG2_H4N4, IgG2_H4N4F1S1, IgG3/4_H4N4F1, IgG3/4_H4N4F1S1), which outperformed CA72-4 for GC diagnosis. Analysis of key glycogenes revealed differential expression patterns, implicating a functional role for IgG N-glycosylation in GC. Notably, the abundance of specific IgG glycosylation exhibited a significant correlation with serum level of IL-11 .  \nConclusions Alterations in subclass-specific IgG N-glycosylation represent promising biomarkers for the detection and monitoring of GC progression, potentially influenced by cytokine-driven inflammation. Understanding  \nthese changes could improve our knowledge of molecular mechanisms, aiding in diagnostic improvements and therapeutic development.  \nKeywords Gastric cancer, IgG N-glycans, IgG glycopeptides, IL-11, Bioinformatics analysis  \n†Tingting Xu and Jianmin Huang contributed equally to this work.  \n*Correspondence: Xin Liu [xliu@mail.hust.edu.cn](xliu@mail.hust.edu.cn)[ ](xliu@mail.hust.edu.cn)Si Liu [siliu@fjmu.edu.cn](siliu@fjmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025, corrected publication 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercialNoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://cre](http://cre)[ativecommons.org/l](ativecommons.org/l)icenses/by-nc-nd/4.0/.  \nXu et al. BMC Cancer (2025) 25:217  \nIntroduction  \nGastric cancer (GC) persists as a lethal malignancy globally, ranking as the fifth most commonly diagnosed cancer and the third primary ca","cbCaidbCeBQPfsHE","https://ap.wps.com/l/cbCaidbCeBQPfsHE","pdf",3608023,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why is profiling IgG N-glycosylation important in gastric cancer?\",\"answer\":\"IgG N-glycosylation alterations are well linked to cancer development, but comprehensive profiling in gastric cancer has been limited. The study aims to clarify prognostic and precursor identification potential of IgG N-glycan patterns.\"},{\"question\":\"How was the IgG N-glycome characterized?\",\"answer\":\"The IgG N-glycome in gastric cancer was characterized using a custom high-throughput orthogonal mass spectrometry approach. Multivariate analysis and bioinformatics were used to identify glycomic alterations and related gene expression changes.\"},{\"question\":\"What biomarkers did the study highlight for gastric cancer progression?\",\"answer\":\"Subclass-specific changes in IgG N-glycosylation, including decreased galactosylation and sialylation in IgG1 and IgG2, were associated with gastric cancer. Specific IgG glycopeptides showed strong diagnostic performance and the abundance correlated with serum IL-11 levels.\"}]","Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression | PDF",1790181182,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83dc3cd42d32b13b62b78fcb0af6151d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c278fa3ad3d033015726e0965429640.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/656619efe7594327357e3f7afd55c876.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45ed2c70435a977ac71258cb2a6900d9.webp",980,1306]